Changes in antibiotic resistance in recurrent Pseudomonas aeruginosa infections of chronic suppurative otitis media

Ear Nose Throat J. 2016 Oct-Nov;95(10-11):446-451.

Abstract

This study investigated the changes in antibiotic resistance in recurrent Pseudomonas aeruginosa infections in chronic suppurative otitis media (CSOM). Its aim was to provide a treatment strategy for P aeruginosa infections in CSOM for the prevention of multidrug resistance. A case-control study was conducted in tertiary teaching hospitals in Korea. The experimental group included patients with recurrent P aeruginosa infection who had relapsed within 2 months after the successful control of a previous P aeruginosa infection. The control group consisted of patients with a P aeruginosa infection who had no history of such an infection. An antibiotic sensitivity test was performed for each culture. The proportion of recurrent P aeruginosa infection was 22.69% (98 of 432 cases). Drug resistance to amikacin, tobramycin, netilmicin, ciprofloxacin, and levofloxacin was significantly changed after recurrent infection. The fluoroquinolone strains seen in recurrent P aeruginosa showed high cross-resistance to other drugs. Antibiotic resistance of P aeruginosa in CSOM changed with recurrent infection.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Amikacin / pharmacology
  • Anti-Bacterial Agents / pharmacology*
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Chronic Disease
  • Ciprofloxacin / pharmacology
  • Drug Resistance, Multiple, Bacterial*
  • Female
  • Humans
  • Infant
  • Levofloxacin / pharmacology
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Netilmicin / pharmacology
  • Otitis Media, Suppurative / drug therapy*
  • Otitis Media, Suppurative / microbiology
  • Pseudomonas Infections / drug therapy*
  • Pseudomonas Infections / microbiology
  • Pseudomonas aeruginosa / drug effects*
  • Recurrence
  • Republic of Korea
  • Retrospective Studies
  • Tobramycin / pharmacology
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Netilmicin
  • Ciprofloxacin
  • Levofloxacin
  • Amikacin
  • Tobramycin